Abstract
Recent evidence suggests that the temporal extent of brain development/maturation can be expanded into middle age when maximal white matter volume and myelination are reached in frontal lobes and association areas. This temporally expanded view of brain development underlies a more comprehensive conceptual model of schizophrenia that incorporates both the reduction of gray matter volume and the complementary expansion of white matter volume occurring from adolescence until middle age. The model posits that the brain is in a constant state of well-regulated structural and functional change roughly defined as periods of development continuing into middle age followed by degeneration. Multiple genetic and environmental factors can interfere with the developmental processes resulting in a dysregulation of the complementary changes occurring in gray and white matter. This dysregulation in development results in an insufficient capacity to maintain temporal synchrony of widely distributed neural networks and is manifested in the heterogeneity of symptoms and cognitive impairments of schizophrenia. The model highlights the contributory role of myelination to synchronous brain function, provides explanations for inconsistencies in the existing literature, and suggests testable hypotheses and novel approaches for intervention efforts.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aboitiz F, Scheibel AB, Fisher RS, Zaidel E . (1992): Fiber composition of the human corpus callosum. Brain Res 598: 143–153
Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG . (1996): Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53: 425–436
Alonso G . (2000): Prolonged corticosterone treatment of adult rats inhibits the proliferation of olygodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 31: 219–231
Andreasen NC, Napoulos P, O′ Leary DS, Miller DD, Wassink T, Flaum M . (1999): Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 46: 908–920
Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linszen DH . (2001): Significantly reduced docosahexaenoic and docosapentaenoic acid concentration in erithrocyte membranes from schizophrenic patients compared to matched control group. Biol Psychiatry 49: 510–522
Baare WFC, van Oel CJ, Hulshoff Pol HE, Schnack HG, Durston S, Sitskoorn MM, Kahn RS . (2001): Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry 58: 33–40
Barbaccia ML, Affricano D, Purdy RH, Maciocco E, Spiga F, Biggio G . (2001): Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharm 25: 489–497
Bartha R, Al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RWJ . (1999): A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry 45: 1403–1411
Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz J . (2002a): Brain maturation is arrested in chronic cocaine addicts. Biol Psychiatry 51: 605–611
Bartzokis G, Beckson M, Lu PH, Nuechterlein K, Edwards N, Mintz J . (2001): Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58: 461–465
Bartzokis G, Mintz J, Marx P, Osborn D, Gutkind D, Chiang F, Phelan CK, Marder S . (1993): Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Res Imaging 11: 993–1006
Bartzokis G, Nuechterlein KH, Lu PH, Edwards N, Mintz J . (2002b): Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study. (submitted)
Bassett AS, Chow EW . (1999): 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Pschiatry 46: 882–891
Basson BR, Kinion BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD . (2001): Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62: 231–238
Baulieu EE, Schumacher M . (2000): Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids 65: 605–612
Bearden CE, van Erp T, Glahn D, Wang PP, Monterosso JR, Zackai E, Emanuel B, Cannon TD . (2001): Structural and functional neuroanatomy in the 22q deletion syndrome. Biol Psychiatry 49: 19S
Benes FM, Turtle M, Khan Y, Farol P . (1994): Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 51: 477–484
Bhakoo KK, Pearce D . (2000): In vitro expression of N-acetyl aspartate in oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74: 254–262
Bock J, Braun K . (1999): Blockade of N-methyl-D-aspartate receptor activation suppresses learning-induced synaptic elimination. Proc Natl Acad Sci USA 96: 2485–2490
Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F . (1992): Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 49: 921–926
Buchanan RW, Vladar K, Barta PE, Pearlson GD . (1998): Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 155: 1049–1055
Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW . (1998): MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9: 425–430
Cannon TD, van Erp TG, Huttunen M, Lonnqvist J, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG, Gur RE, Yan M . (1998): Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 55: 1084–1091
Castle D, Sham P, Murray R . (1998): Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Res 33: 179–183
Chan JR, Phillips LJ, Glaser M . (1998): Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci USA 95: 10459–10464
Chance SA, Highley JR, Esiri MM, Crow TJ . (1999): Fiber content of the fornix in schizophrenia: lack of evidence for a primary limbic encephalopathy. Am J Psychiatry 156: 1720–1724
Chow EW, Mikulis DJ, Zipursky RB, Scutt LE, Weksberg R, Bassett AS . (1999): Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 46: 1436–1442
Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP . (2002): Reduced neuronal size and glia cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12: 386–394
Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P . (1998): Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry 43: 783–793
Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JM, Lieberman JA . (1992): Volumes of ventricular system subdivisions measured from magnetic resonance images in first episode schizophrenic patients. Arch Gen Psychiatry 49: 531–537
Demerens C, Stankoff B, Zalc B, Lubetzki C, Eliprodil . (1999): Stimulates CNS myelination: new prospects for multiple sclerosis? Neurology 1999: 346–350
DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R . (1997): Schizophrenia as a chronic brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res: Neuroimaging 74: 129–140
DeLisi LE, Striktzke P, Riordan H, Holan V, Boccio A, Kushner M, McClelland J, Van Eyl O, Anand A . (1992): The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry 31: 241–254
DeLisi LE . (1997): Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophrenia Res 23: 119–129
Demczuk S, Aurias A . (1995): DiGeorge syndrome and related syndromes associated with 22q11.2 deletions: a review. Ann Genet 38: 59–76
Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, Schumacher M . (1998): Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 71: 1765–1768
Du Montcel ST, Mendizabal H, Ayme S, Levy A, Philip N . (1996): Prevalence of 22q11 microdeletion. J Med Genet 33: 719
Eliez S, Antonarakis SE, Morris MA, Dahoun SP, Reiss AL . (2001): Parental origin of the deletion 22q11.2 and brain development in velofacial syndrome. Arch Gen Psychiatry 58: 64–68
Eliez S, Schmitt JE, White CD, Reiss AL . (2000): Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 157: 409–415
Etienne P, Baudry M . (1990): Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology; an integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes. J Neural Transm 29(suppl):39–48
Foong J, Maier M, Barker GJ, Brocklehurst S, Miller DH, Ron MA . (2000): In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurolog Neurosurg Psychiatry 68: 70–74
Friedman JI, Harvey PD, Kamether E, Byne W, Davis KL . (1999): Cognitive and functional changes with aging in schizophrenia. Biol Psychiatry 46: 921–928
Friston KJ . (1998): The disconnection hypothesis. Schizophr Res 30: 115–125
Friston KJ, Frith CD . (1995): Schizophrenia: a disconnection syndrome? Clin Neurosci 3: 89–95
Fukuzako H, Fukuzako T, Hashiguchi T, Kodama S, Takigawa M, Fujimoto T . (1999): Changes in levels of phosphorus metabolites in temporal lobes of drug-naïve schizophrenic patients. Am J Psychiatry 156: 1205–1208
Fuster JM . (1999): Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatrica Scandinavia 99: 51–57
Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL . (1999a): Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2: 861–863
Giedd JN, Jeffries NO, Blumenthal J, Castellanos FX, Vaituzis AC, Fernandez T, Hamburgen SD, Liu H, Nelson J, Bedwell J, Tran L, Leane M, Nicolson R, Rapoport JL . (1999b): Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry 46: 892–898
Gould E, Reeves AJ, Graziano MSA, Gross CG . (1999): Neurogenesis in the neocortex of adult primates. Science 286: 548–552
Green MF . (1999): Cortical oscillations and schizophrenia. Arch Gen Psychiatry 56: 1007–1008
Gur RC, Turetsky BI, Matsui M, Yan M, Bilker W, Hughett P, Gur RE . (1999): Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance. J Neurosci 19: 4065–4072
Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC . (2000a): Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry 57: 761–768
Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC . (1998): Subcortical MRI volumes in neuroleptic-naïve and treated patients with schizophrenia. Am J Psychiatry 155: 1711–1717
Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, Arnold SE, Bilker WB, Gur RC . (2000b): Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 57: 769–775
Haas GL, Garratt LS, Sweeney JA . (1998): Delay to first antipsychotic medication in schizophrenia: impact on symptomology and clinical course of illness. J Psychiatr Res 32: 151–159
Hafner H, Hambrecht M, Loffler W, Munk-Jorgensen P, Riecher-Rossler A . (1998): Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med 28: 351–365
Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA . (2001): Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746–4751
Harrison PJ . (1999): The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 122: 593–624
Harvey PD, Moriarty PJ, Friedman JI, White L, Parrella M, Mohs RC, Davis KL . (2000): Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas. Biol Psychiatry 47: 962–968
Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, Davidson M, David KL . (1999): Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry 45: 32–40
Haug H . (1987): Brain sizes, surfaces, and neuronal sizes of the cortex cerebri: a stereological investigation of man and his variability and a comparison with some mammals (primates, whales, marsupials, insectivores, and one elephant). Am J Anat 180: 126–142
Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC . (2000): Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 157: 975–981
Horrobin DF, Bennett CN . (1999): New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukotrines Essnt Fatty Acids 60: 141–167
Huttenlocher PR, Dabholkar AS . (1997): Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167–178
Huttenlocher PR . (1979): Synaptic density in the human frontal cortex: developmental changes and effects of aging. Brain Res 163: 195–205
Hyde TM, Ziegler JC, Weinberger DR . (1992): Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol 49: 401–406
Illowsky BP, Juliano DM, Bigelow LB, Weinberger DR . (1988): Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurology Neurosurgery Psychiatry 51: 209–213
Jernigan TL, Archibald SL, Berhow MT, Sowell ER, Foster DS, Hesselink JR . (1991): Cerebral structure on MRI, part I: localization of age-related changes. Biol Psychiatry 29: 55–67
Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG . (2000): Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res 22: 330–336
Kates WR, Burnette CP, Jabs EW, Rutberg J, Murphy AM, Gardos MA, Geraghty M, Kaufmann WE, Pearlson GD . (2001): Regional cortical white matter reductions in velocardiofacial syndrome: A volumetric MRI analysis. Biol Psychiatry 49: 677–684
Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW . (1998): Decreased caudate volume in neuroleptic-naïve psychotic patients. Am J Psychiatry 155: 774–778
Khan MM, Parikh VV, Mahadik SP . (2002): Effects of chronic exposure of antipsychotics on apolipoprotein D in rat brain. Biol Psychiatry 51: 168S
Kirkpatrick B, Conley RC, Kakoyannis A, Reep RL, Roberts RC . (1999): Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study. Synapse 34: 95–102
Koenig HL, Gong WH, Pelissier P . (2000): Role of progesterone in peripheral nerve repair. Rev Reprod 5: 189–199
Lawrie SM, Abukmeil SS . (1998): Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies [see comments]. Br J Psychiatry 172: 110–120
Levy R, Goldman-Rakic PS . (2000): Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp Brain Res 133: 23–32
Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R . (2001): Longitudinal study of brain morpology in first episode schizophrenia. Biol Psychiatry 49: 487–499
Lieberman JA, Duncan G, Marx C, Grobin C, Morrow L . (2001a): Atypical and Conventional Antipsychotic Drugs: Comparative Effects and Mechanism of Action. Abstracts of the 40th Annual Meeting of the ACNP, Hawaii, December 2001.
Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A . (1998): Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 55: 346–352
Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A . (1999): Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56: 367–374
Lim KO, Zipursky RB, Watts MC, Pfefferbauum A . (1992): Decreased gray matter in normal aging: An in vivo magnetic resonance study. J Gerontol 47: B26–B30
Maier M, Ron MA . (1996): Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophrenia Res 22: 5–17
Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL . (2000): Olanzapine increases allopregnenalone in the rat cerebral cortex. Biol Psychiatry 47: 1000–1004
Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A . (2001): Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 58: 148–157
McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME . (1999): MRI anatomy of schizophrenia. Biol Psychiatry 45: 1099–1119
McDonald JW, Althomsons SP, Choi DW, Goldberg MP . (1998): Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4: 291–297
McGlashan TH . (1999): Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 46: 899–907
McGlashan TH, Hoffman RE . (2000): Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57: 637–648
McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL . (2000): The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Res 42: 47–55
Melcangi RC, Magnaghi I, Cavarretta L, Martini L, Piva F . (1998): Age-induced decrease of glycoprotein PO and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85: 569–578
Melkersson KI, Hulting AL, Brismar KE . (2000): Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 61: 742–749
Mesulam M . (2000): Principles of Behavioral and Cognitive Neurology, 2nd ed. New York, Oxford Univ Press
Miller AK, Alston RL, Corsellis JA . (1980): Variation with age in the volumes of grey and white matter in the cerebral hemisphere of man: measurements with an image analyser. Neuropathol Appl Neurobiol 6: 119–132
Miller EK . (2000): The prefrontal cortex and cognitive control. Nature Reviews Neuroscience 1: 59–65
Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RLM, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S . (2002): Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. PANS 99: 4680–4685
Montpied P, de Bock F, Lerner-Natoli M, Bockaert J, Rondouin G . (1999): Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res 35: 135–146
Murphy KJ, Regan CM . (1998): Contributions of cell adhesion molecules to altered synaptic weighting during memory consolidation. Neurobiol Learn Mem 70: 73–81
Navarro A, Tolivia J, Astudillo A, del Valle E . (1998): Pattern of apolipoprotein D immunoreactivity in human brain. Neurosci Lett 254: 17–20
Nelson MD, Saykin AJ, Flashman LA, Riordan HJ . (1998): Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55: 433–440
Nuechterlein KH, Dawson ME, Gitlin M, Vemtura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J . (1986): A heuristic vulnerability/stress model of schizophrenic episodes. Schizoph Bull 10: 300–312
Ohara K, Xu HD, Matsunaga T, Xu DS, Huang XQ, Gu GF, Ohara K, Wang ZC . (1998): Cerebral ventricle-brain ratio in monozygotic twins discordant and concordant for schizophrenia. Progress Neuro-Psychopharm Biol Psychiatry 22: 1043–1050
Ong WY, Lau CP, Leong SK, Kumar U, Suresh S, Patel SC . (1999): Apolipoprotein D gene expression in the rat brain and light and electron microscopic immunocytochemistry of apolipoprotein D expression in the cerebellum of neonatal, immature adult rats. Neurosci 1999; 90: 913–922
Pakkenberg B, Gundersen HJ . (1997): Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384: 312–320
Passe TJ, Rajagopalan P, Tupler LA, Byrum CE, MacFall JR, Krishnan KRR . (1997): Age and sex effects on brain morphology. Prog Neuropsychopharmacol Biol Psychiatry 21: 1231–1237
Patel SC, Asotra K, Patel YC, McConathy WJ, Patel RC, Suresh S . (1995): Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6: 653–6658
Pearlson GD, Marsh L . (1999): Structural brain imaging in schizophrenia: A selective review. Biol Psychiatry 46: 627–649
Peters A, Morrison JH, Rosene DL, Hyman BT . (1998): Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 8: 295–300
Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M . (1991): Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48: 563–568
Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO . (1994): A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51: 874–887
Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL . (1998): Alzheimer disease and related neurodegenerative disease in elderly patients with schizophrenia. Arch Gen Psychiatry 55: 205–211
Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicholson R, Bedwell J, Leane M, Zijdenbos A, Paus T, Evans A . (1999): Progressive cortical change during adolescence in childhood-onset schizophrenia: A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 56: 649–654
Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R . (2000): Apolipoprotein D. Biochimi Biophys Acta 1482: 185–198
Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, Loken WJ, Thorton AE, Acker JD . (1997): Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 7: 268–282
Sachdev P, Brodaty H, Rose N, Cathcart S . (1999): Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. Br J Psychiatry 175: 416–421
Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A . (2000): Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry 57: 471–480
Sapolsky RM . (2000): Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57: 925–935
Schaeren-Wiemers N, Schaefer C, Valenzuela DM, Yancopoulos GD, Schwab ME . (1995): Identification of new oligodendrocyte- and myelin-specific genes by a differential screening approach. J Neurochem 65: 10–22
Seidman LJ, Faraone SV, Goldstein JM, Goodman JM, Kremen WS, Toomey R, Tourville J, Kennedy D, Makris N, Caviness VS, Tsuang MT . (1999): Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol Psychiatry 46: 941–954
Selemon LD, Goldman-Rakic PS . (1999): The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry 45: 17–25
Sestan N, Artevanis-Tsakonas S, Rakic P . (1999): Contact-dependent inhibition of cortical neurite growth mediated notch signaling. Science 286: 741–746
Sheline YI . (1996): Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity. Mol Psychiatry 1: 298–299
Srinivasan R . (1999): Spatial structure of the human alpha rhythm: global correlation in adults and local correlation in children. Clin Neurophysiol 110: 1351–1362
Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn ML, Jellema K, Kahn RS . (2000): Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry 157: 416–421
Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A . (1995): Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 16: 591–606
Suresh S, Yan Z, Patel RC, Patel YC, Patel SC . (1998): Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem 70: 242–251
Symonds LL, Archibald SL, Grant I, Zisook S, Jernigan TL . (1999): Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? J Neuroimaging 9: 201–209
Takahashi S, Matsuura M, Tanabe E, Yara K, Nonaka K, Fukura Y, Kikuchi M, Kojima T . (2000): Age at onset of schizophrenia: gender differences and influence of temporal socioeconomic change. Psychiatry Clin Neurosci 54: 153–156
Takao M, Koto A, Tanahashi N, Fukuuchi Y, Takagi M, Morinaga S . (1999): Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci 167: 127–131
Terry RD, DeTeresa R, Hansen LA . (1987): Neocortical cell counts in normal human adult aging. Ann Neurol 21: 530–539
Thomas EA, Danielson PE, Nelson PA, Pribyl TM, Hilbush BS, Hasel KW, Sutcliffe JG . (2001a): Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J Neurochem 76: 789–796
Thomas EA, Dean B, Pavey G, Sutcliffe JG . (2001b): Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders. PANS 98: 4066–4071
Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans AC, Toga AW . (2000): Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404: 190–193
Tonkonogy JM, Geller JL . (1999): Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry Neuropsychol Behav Neurol 12: 230–235
Uranova N, Orlovskaya D, Vikhreva O, Zimina L, et-al. (2001): Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55: 597–610
Valk J, van der Knaap MS . (1989): Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. New York, Springer-Verlag
Walder DJ, Walker EF, Lewine RJ . (2000): Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry 48: 1121–1132
Watzka M, Bidlingmaier F, Schramm J, Klingmuller D, Stoffel-Wagner B . (1999): Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J Neuroendocrinol 11: 901–905
Weinberger DR, Lipska BK . (1995): Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophrenia Res 16: 87–110
Weinberger DR . (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660–669
Welham J, McLachlan G, Davies G, McGrath J . (2000): Heterogeneity in schizophrenia; mixture modeling of age-at-first-admission, gender and diagnosis. Acta Psychiatr Scand 101: 312–317
Woods BT . (1998): Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 155: 1661–1670
Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET . (2000): Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157: 16–25
Wyatt RJ, Henter ID . (1998): The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res 32: 169–177
Yakovlev PI, Lecours AR . (1967): The myelogenetic cycles of regional maturation of the brain. In Minkowski A (ed), Regional Development of the Brain in Early Life. Boston, Blackwell Scientific Publications, pp 3–70
Zwain IH, Yen SS . (1999): Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140: 3843–3852
Acknowledgements
This work was supported by the Research and Psychiatry Services of the Department of Veterans Affairs, the National Alliance for Research on Schizophrenia and Depression, NIMH grant MH-51928, and the Marie Wilson Howells Endowment. The author thanks Po H. Lu for editorial support and Lori Altshuler, M.D., for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bartzokis, G. Schizophrenia: Breakdown in the Well-regulated Lifelong Process of Brain Development and Maturation. Neuropsychopharmacol 27, 672–683 (2002). https://doi.org/10.1016/S0893-133X(02)00364-0
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(02)00364-0
Keywords
This article is cited by
-
Abnormalities in thalamo-cortical connections in patients with first-episode schizophrenia: a two-tensor tractography study
Brain Imaging and Behavior (2019)
-
Tryptophan Metabolism and White Matter Integrity in Schizophrenia
Neuropsychopharmacology (2016)
-
Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients
Molecular Psychiatry (2015)
-
Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
Translational Psychiatry (2015)
-
Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains
European Archives of Psychiatry and Clinical Neuroscience (2015)
